Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2005
|
| gptkbp:ATCCode |
gptkb:J05AF10
|
| gptkbp:CASNumber |
209216-23-9
|
| gptkbp:chemicalFormula |
C12H15N5O3
|
| gptkbp:eliminationHalfLife |
128-149 hours
|
| gptkbp:form |
gptkb:tablet
oral solution |
| gptkbp:genericName |
gptkb:entecavir
|
| https://www.w3.org/2000/01/rdf-schema#label |
Baraclude
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:mechanismOfAction |
nucleoside analogue reverse transcriptase inhibitor
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
dizziness fatigue headache insomnia |
| gptkbp:usedFor |
chronic hepatitis B
|
| gptkbp:bfsParent |
gptkb:entecavir
|
| gptkbp:bfsLayer |
6
|